BR112012019169A2 - composto, composição farmacêutica, e, uso da mesma - Google Patents
composto, composição farmacêutica, e, uso da mesmaInfo
- Publication number
- BR112012019169A2 BR112012019169A2 BR112012019169A BR112012019169A BR112012019169A2 BR 112012019169 A2 BR112012019169 A2 BR 112012019169A2 BR 112012019169 A BR112012019169 A BR 112012019169A BR 112012019169 A BR112012019169 A BR 112012019169A BR 112012019169 A2 BR112012019169 A2 BR 112012019169A2
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- hydrogen
- substituted
- fluoro
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
- C07C291/08—Azoxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
composto, composição farmacêutica, e, método para tratar hipertensão em um paciente. um composto tendo a estrutura ou um sal farmaceuticamente aceitável do mesmo, em qu r^1^ é hidrogênio, -oh, -o-alquila c~1~-~6~, =o, ou halogênio; r^2^ é hidrogênio, -c(o)or^8^, -c~6~h~5~c(o)or^8^, -(ch~2~)~1~-~2~oh, -cr^9^r^10^oh, -c(o)o(ch~2~)~0~-~2~ arila, -c(o)nr^9^r^10^, -c(o)so~2~nr^9^r^10^, -c~6~h~5~or^9^, -w-c(o)or^8^, -w-or^9^, -y, ou -p(o)(or^9^)(or^10^); r^3^ é hidrogênio ou -alquila c~1~-~6~; r^4^ é hidrogênio, -oh, ou -c(o)or^9^; r^5^ é hidrogênio ou deutério; r^6^ e r^7^ são independentemente alquila c~1~-~6~ substituído por fluoro, alquila c~1~-~6~ substituído por deutero ou -(ch~2~)~1~-~2~r^11^, em que qualquer átomo de carbono do alquila c~1~-~6~ substituído por fluoro é mono- ou di-substituído com fluoro e qualquer átomo de carbono do alquila c~1~-~6~ substituído por deutero é mono- ou di-substituído com fluoro; r^8^, em cada caso em que o mesmo ocorre, é independentemente hidrogênio, -alquila c~1~-~6~, ou -(ch~2~)~2~n+(ch~3~)~3~; r^9^ e r^10^, em cada exemplo em que eles ocorrem, são independentemente -alquila c~1~-~6~; r^11^ é -oh, -o-alquila c~1~-~6~, -ocd~3~, -oc(o)o alquila c~1~-~6~, -nh~2~, -c~6~h~5~, -n~3~, ou w; w é um anel de heteroarila de 5 ou 6 membros não substituído tendo 1,2, ou 3 átomos de nitrogênio, ou um anel de heteroarila de 5 ou 6 membros substituído tendo 1,2, ou 3 átomos de nitrogênio que é mono ou di-substituído em qualquer átomo de carbono com r^6^ ou r^7^; y é um anel heterocílico de 5 ou 6 membros tendo 1,2,3, ou 4 heteroátomos que são n, o ou s, ou estereoisômeros destes, ou seus sais farmaceuticamente aceitáveis, ou sais farmaceuticamente aceitáveis de estereoisômeros destes e métodos de usar os compostos para tratar a hipertensão.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30392710P | 2010-02-12 | 2010-02-12 | |
PCT/US2011/024275 WO2011100384A1 (en) | 2010-02-12 | 2011-02-10 | Diazeniumdiolate cyclopentyl derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012019169A2 true BR112012019169A2 (pt) | 2018-02-06 |
Family
ID=44368111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012019169A BR112012019169A2 (pt) | 2010-02-12 | 2011-02-10 | composto, composição farmacêutica, e, uso da mesma |
Country Status (11)
Country | Link |
---|---|
US (1) | US8648058B2 (pt) |
EP (1) | EP2533644B1 (pt) |
JP (1) | JP2013519677A (pt) |
KR (1) | KR20130008523A (pt) |
CN (1) | CN102883610A (pt) |
AU (1) | AU2011215881A1 (pt) |
BR (1) | BR112012019169A2 (pt) |
CA (1) | CA2787035A1 (pt) |
MX (1) | MX2012009340A (pt) |
RU (1) | RU2012138955A (pt) |
WO (1) | WO2011100384A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130143042A (ko) * | 2010-10-29 | 2013-12-30 | 머크 샤프 앤드 돔 코포레이션 | 디아제늄디올레이트 헤테로시클릭 유도체 |
EP2704568B1 (en) | 2011-05-02 | 2018-01-24 | Merck Sharp & Dohme Corp. | Diazeniumdiolate cyclohexyl derivatives |
US9578505B2 (en) * | 2015-04-21 | 2017-02-21 | International Business Machines Corporation | Authentication of user computers |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69223157T2 (de) * | 1991-09-24 | 1998-06-10 | Us Health | Sauerstoff-substituierte derivate von nucleophil-stickstoffoxid-addukten und ihre verwendung als stickstoffoxid-donor-prodrugs |
US20050137191A1 (en) | 1996-06-04 | 2005-06-23 | Thatcher Gregory R. | Nitrate esters and their use for mitigating cellular damage |
US5807847A (en) | 1996-06-04 | 1998-09-15 | Queen's University At Kingston | Nitrate esters |
EP2292630B1 (en) * | 1996-09-27 | 2015-11-25 | The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
US20050065194A1 (en) | 2003-01-16 | 2005-03-24 | Geetha Shankar | Methods of treating conditions associated with an Edg-2 receptor |
FR2902428B1 (fr) * | 2006-06-15 | 2008-08-15 | Servier Lab | Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AR069340A1 (es) | 2007-11-26 | 2010-01-13 | Merck & Co Inc | Antagonistas del receptor de angiotensina ii |
FR2924713B1 (fr) | 2007-12-11 | 2010-01-29 | Servier Lab | Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AU2009206635A1 (en) * | 2008-01-24 | 2009-07-30 | Merck Sharp & Dohme Corp. | Angiotensin II receptor antagonists |
-
2011
- 2011-02-10 AU AU2011215881A patent/AU2011215881A1/en not_active Abandoned
- 2011-02-10 MX MX2012009340A patent/MX2012009340A/es not_active Application Discontinuation
- 2011-02-10 US US13/577,797 patent/US8648058B2/en active Active
- 2011-02-10 JP JP2012552980A patent/JP2013519677A/ja not_active Withdrawn
- 2011-02-10 RU RU2012138955/04A patent/RU2012138955A/ru not_active Application Discontinuation
- 2011-02-10 BR BR112012019169A patent/BR112012019169A2/pt not_active IP Right Cessation
- 2011-02-10 CN CN2011800085447A patent/CN102883610A/zh active Pending
- 2011-02-10 KR KR1020127021006A patent/KR20130008523A/ko not_active Application Discontinuation
- 2011-02-10 WO PCT/US2011/024275 patent/WO2011100384A1/en active Application Filing
- 2011-02-10 CA CA2787035A patent/CA2787035A1/en not_active Abandoned
- 2011-02-10 EP EP11742769.0A patent/EP2533644B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20130053352A1 (en) | 2013-02-28 |
CA2787035A1 (en) | 2011-08-18 |
EP2533644A4 (en) | 2013-08-14 |
EP2533644B1 (en) | 2017-01-18 |
MX2012009340A (es) | 2012-09-07 |
KR20130008523A (ko) | 2013-01-22 |
AU2011215881A1 (en) | 2012-07-26 |
US8648058B2 (en) | 2014-02-11 |
WO2011100384A1 (en) | 2011-08-18 |
JP2013519677A (ja) | 2013-05-30 |
CN102883610A (zh) | 2013-01-16 |
RU2012138955A (ru) | 2014-03-20 |
EP2533644A1 (en) | 2012-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014027181A2 (pt) | derivados de benzamida para a inibição da atividade de abl1, abl2 e bcr-abl1 | |
CY1124882T1 (el) | Αναλογα 1,4-διϋποκατεστημενης πυριδαζινης και μεθοδοι για την θεραπευτικη αγωγη καταστασεων συναφων με ανεπαρκεια smn | |
CO7131380A2 (es) | Derivados de benzamida para la inhibición de la actividad de abl1, abl2 y bcr-abl1 | |
CY1118572T1 (el) | Παραγωγο κυκλοαλκανιου | |
MY196486A (en) | 6,7-Dihydro-5h-Benzo[7]Annulene Derivatives as Estrogen Receptor Modulators | |
BR112015018751A2 (pt) | derivados de piridazinona macrocíclicos | |
EA201490726A1 (ru) | Фармацевтические соединения для применения в терапии инфекции clostridium difficile | |
BR112017025969A2 (pt) | métodos, e métodos para produzir monofosfato de tiaminila, de piridoxila, de adenosila, ou um sal dos mesmos | |
UA110259C2 (uk) | Похідні піролопіримідину і пурину | |
BR112015019590A2 (pt) | derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv | |
BR112013006594A2 (pt) | composto, composição farmacêutica, método de tratamento de um distúrbio, e, uso de um composto | |
CU24030B1 (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen | |
MY170262A (en) | Dicarboxylic acid compound | |
BR112012019169A2 (pt) | composto, composição farmacêutica, e, uso da mesma | |
BR112018069712A2 (pt) | composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a. | |
BR112014001083A8 (pt) | composto, processo para a preparação de um composto, composição farmacêutica, método para o tratamento de doenças e uso de um composto | |
BR112014019402A8 (pt) | Composto 2-aril-benzofuran-7-carboxamida, ou sal farmacologicamente aceitável do mesmo e método para a preparação do composto | |
FR2942625B1 (fr) | Derives indoliques pour le traitement de maladies neurodegeneratives | |
BR112015006979A2 (pt) | compostos anti-invasivos | |
MY160253A (en) | Prophylactic or ameliorating agent for pigmentation | |
RU2014126394A (ru) | Новые соединения - ингибиторы липогенеза | |
MX345264B (es) | Derivado de azol. | |
RU2014123690A (ru) | Терапевтическое средство при артрозе | |
BR112016009918A2 (pt) | composto tendo maior inibição da atividade da proteína cinase g e método de preparação para tal | |
MX2015002705A (es) | Compuestos de piridinona para usarse en terapia fotodinamica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |